ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Definition, epidemiology, and etiology of obesity in children and adolescents

Definition, epidemiology, and etiology of obesity in children and adolescents
Literature review current through: Jan 2024.
This topic last updated: Dec 08, 2023.

INTRODUCTION — Obesity has become one of the most important public health problems in the United States and many other resource-abundant settings and transitional economies [1-3]. As the prevalence of obesity has increased, so has the prevalence of the comorbidities associated with obesity [2]. For this reason, it is imperative that health care providers identify overweight and obese children so that counseling and treatment can be provided.

The definition, epidemiology, and etiology of obesity in children and adolescents will be presented here. Related content on childhood obesity can be found in the following topic reviews:

(See "Prevention and management of childhood obesity in the primary care setting".)

(See "Clinical evaluation of the child or adolescent with obesity".)

(See "Overview of the health consequences of obesity in children and adolescents".)

(See "Surgical management of severe obesity in adolescents".)

DEFINITIONS — The term "obesity" refers to an excess of fat. However, the methods used to directly measure body fat are not available in daily practice. For this reason, obesity usually is assessed by the relationship between weight and height (ie, anthropometrics), which provides an estimate of body fat that is sufficiently accurate for clinical purposes.

Body mass index (BMI) is the widely accepted standard measure of overweight and obesity for children two years of age and older [4-6]. BMI provides a guideline for weight in relation to height and is equal to the body weight (in kilograms) divided by the height (in meters) squared (table 1). Other indices of childhood obesity, including weight-for-height (which is particularly useful for the child younger than two years), measures of regional fat distribution (eg, waist circumference and waist-to-hip ratio), and the growth standards developed by the World Health Organization (WHO), are discussed separately. (See "Measurement of body composition in children" and "Measurement of growth in children", section on 'Growth references and standards'.)

Because children grow in height as well as weight, the norms for BMI in children vary with age and sex. In 2000, the National Center for Health Statistics (NCHS) and the Centers for Disease Control and Prevention (CDC) published BMI reference standards for children between the ages of 2 and 20 years (figure 1A-B). BMI percentiles also can be determined using a calculator for females (calculator 1) and for males (calculator 2). As children approach adulthood, the thresholds for defining overweight and obesity (85th and 95th percentiles for BMI) are approximately 25 and 30 kg/m2, respectively, which represent the same thresholds for defining overweight and obesity in adults.

The following definitions are used to categorize weight status for children between 2 and 20 years of age (table 2) [4]:

Underweight – BMI <5th percentile for age and sex.

Normal weight – BMI between the 5th and <85th percentile for age and sex.

Overweight – BMI between >85th and 95th percentile for age and sex.

Obesity – Classified by severity, using the following thresholds ( (figure 2A-B) or CDC extended BMI growth charts) [4,7,8]:

Class I – BMI ≥95th percentile for age and sex or BMI ≥30 (whichever is lower).

Class II – BMI ≥120 percent of the 95th percentile values or a BMI ≥35 kg/m2 (whichever is lower). This threshold approximates the 98th percentile after age seven years but is above the 98th percentile in younger children [9].

Class III obesity – BMI ≥140 percent of the 95th percentile values or a BMI ≥40 kg/m2. This threshold is between the 99th and 99.9th percentiles after age seven years [9].

The above definition of severe obesity in children and adolescents is recommended because it is clinically practical and because the CDC growth standards are not sufficiently precise to use percentile curves or Z-scores at the extremes [10,11]. In males, the curve for 120 percent of the 95th percentile reaches a BMI of 35 kg/m2 at age 18 years, corresponding to class II obesity in adults. In females, the corresponding curve reaches a BMI of 35 kg/m2 around age 16.5 years. (See "Obesity in adults: Prevalence, screening, and evaluation".)

Children with severe obesity represent approximately 5 percent of children and adolescents in the United States, with the highest prevalence in Black and Mexican-American youth [7,12,13]. Among adolescents between 12 and 19 years of age, the prevalence of severe obesity is approximately 7 percent in females and 9.7 percent in males [7]. This group has significantly more cardiovascular risk factors and a greater risk for having obesity in adulthood [13]. Therefore, this threshold appears to define a group with medically significant obesity in children and adolescents. (See "Surgical management of severe obesity in adolescents", section on 'Consequences of severe obesity'.)

The term "morbid obesity" is sometimes used to identify individuals with obesity-related comorbidities. However, this term is often inappropriately used as a synonym for severe obesity, and it also may have pejorative connotations to patients, so its use is discouraged. (See "Overview of the health consequences of obesity in children and adolescents".)

In the discussion that follows, the term "obesity" refers to children with BMI ≥95th percentile for age and sex and "overweight" refers to children with BMI between the 85th and 95th percentile for age and sex, unless otherwise noted.

EPIDEMIOLOGY

Prevalence

United States – Approximately one-third of children and adolescents in the United States are either overweight or obese [7]. The population is distributed into higher weight categories with advancing age, as shown below (in which each weight category is inclusive of the higher weight categories) (figure 3):

Overweight (body mass index [BMI] ≥85th to 95th percentile)

-12.3 percent of preschool-aged children (2 to 5 years)

-15.4 percent of school-aged children (6 to 11 years)

-19.4 percent of adolescents (12 to 19 years)

Class I obesity (BMI ≥95th percentile to <120 percent of the 95th percentile and <35 kg/m2)

-11.7 percent of preschool-aged children

-12.3 percent of school-aged children

-8.9 percent of adolescents

Class II or III obesity (BMI that is either ≥120 percent of the 95th percentile or ≥35 kg/m2)

-2 percent of preschool-aged children

-6.4 percent of school-aged children

-10.1 percent of adolescent females and 13.2 percent of adolescent males

The BMI percentiles are defined by the growth charts developed by the Centers for Disease Control and Prevention (CDC) to reflect a generally healthy population, in which the prevalence of overweight and obesity are 15 and 5 percent, respectively, by definition. The actual prevalence of overweight and obesity listed above indicates that the weight status of the population is considerably less healthy than the reference population. The prevalences of overweight and obesity are somewhat lower if the percentiles are adjusted for pubertal status, but this adjustment is not routinely performed in clinical care or research [14].

Childhood obesity is more common among Native American, Black, and Mexican American children than in non-Hispanic White children [3,7,15]. A child’s risk of having obesity is two- to three-fold higher if they have one birth parent with obesity, and up to 15-fold if they have two birth parents with obesity [16]. Obesity is also more prevalent among populations with lower income, education levels or those living in rural environments [15,17]. As an example, 14.9 percent of low-income preschool-aged children had obesity in 2010, compared with 12.1 percent in this age group in the general population [18].

Other countries – The prevalence of childhood overweight and obesity is high in most resource-abundant settings worldwide [2,19]. It is difficult to directly compare prevalence rates between countries because of differences in definitions and dates of measurements. Use of the International Obesity Task Force (IOTF) standards typically results in lower prevalence estimates than other standards [20,21]. However, studies using comparable statistics show that rates are particularly high (greater than 30 percent) in most countries in North and South America, as well as in Great Britain, Greece, Italy, Malta, Portugal, and Spain (figure 6B) [22]. There are somewhat lower rates in Nordic countries, France, and Central Europe [2]. In Russia and most of the countries of Eastern Europe, the prevalence of overweight is lower (approximately 15 percent) but increasing. In China, the prevalence of overweight among children is approximately one-half of that in the United States, but rates are substantially higher in young children than in adolescents [23].

Trends

United States – In the United States, the prevalence of obesity rose dramatically in the last few decades of the 20th century and beginning of the 21st century. After the early 2000s, there was a plateau in the overall prevalence of obesity, but the prevalence of severe obesity has continued to climb. The pattern varied slightly by age group: Among school-aged children (6 to 11 years), the prevalence of obesity increased dramatically from 6.5 percent in 1976-1980 to 19.3 percent in 2015-2018 (figure 4) [3,24]. In this age group, the trend was increasing until 2007-2008 and then remained more or less stable through 2018 [3]. Among adolescents (12 to 19 years), the prevalence of obesity increased from 5 percent in 1976-1980 to 20.9 percent in 2015-2018, with no significant plateau [3,24].

For preschool-aged children (aged two to five years) in the United States, data from the National Health and Nutrition Examination Survey (NHANES) are mixed but show an overall plateau since the early 2000s (figure 4) [3,25,26]. Modestly decreasing trends in this young age group were reported in various studies and subgroups between 2004-2012 [26-32], but this was followed by resumption of an upward trend through 2018 [3,7].

Despite the plateau in overall prevalence of childhood obesity in the United States, the prevalence of severe obesity continues to increase. Severe obesity among children 2 to 19 years old increased across the NHANES survey from 2.6 percent (1988-1994), to 5.1 percent (2003-2004), to 6.0 percent (2015-2016) [25]. In 2016, 6 percent of children had class II obesity (BMI ≥120 percent of the 95th percentile or ≥35 kg/m2) and 1.9 percent had class III obesity (BMI ≥140 percent of the 95th percentile or ≥40 kg/m2) [7].

Other countries – Worldwide, overweight and obesity in children have generally increased across a wide range of resource-abundant and resource-limited countries during the past 50 years (figure 5 and figure 6A-B), with several higher-income countries reporting more recent plateauing or decreases [19]. The rate at which childhood obesity is increasing in middle- and low-income countries is 30 percent higher than the rate of increase in high-income countries [33,34]. Plateaus in the prevalence of childhood obesity are reported in population studies from Australia [35] and France [36], and decreasing rates were reported in Germany [37], Switzerland [38], Spain [39], and Canada [40]. For preschool-aged children, stable or decreasing trends were reported in New Zealand, Victoria (Australia), England and Germany [41,42].

Coronavirus disease 2019 (COVID-19)-related changes – The COVID-19 pandemic was associated with increases in childhood obesity in several countries [43-46]. As an example, in a large health care system in California, the prevalence of obesity rose among all age groups during the first year of the pandemic; the greatest change was among children 5 to 11 years old, among whom the prevalence of obesity rose from 19 to 26 percent [43]. Similar trends were seen in a nationwide sample [47]. Other studies report that the pandemic exacerbated risk factors for obesity, disproportionately impacting urban and low-income populations [46,48,49]. (See "COVID-19: Management in children", section on 'Physical health effects'.)

Persistence into adulthood — Many but not all obese children will become obese adults. The likelihood of persistence of childhood obesity into adulthood (sometimes called "tracking") is related to age [50-54], parental obesity [16,55,56], severity of obesity [53,57-59], and BMI trajectory during childhood [60]. These observations provide support for the concept of interventions early in life to prevent and treat obesity. (See "Prevention and management of childhood obesity in the primary care setting", section on 'Evidence for efficacy'.)

Longitudinal studies reveal that a substantial component of adolescent obesity is established before five years of age. In a large study from the United States, children who were overweight at entry into kindergarten were four times as likely to become obese by 8th grade as compared with those who were not overweight [58]. Moreover, the severity of obesity was an important predictor of persistence. Among children who had mild obesity at entry into kindergarten (mean age 5.6 years), 47 percent remained obese in 8th grade (mean age 14.1 years). Among those who had severe obesity (BMI 99th percentile) in kindergarten, more than 70 percent remained obese in 8th grade (figure 7). Similar findings were reported in a large population study from Germany, in which almost 90 percent of children who were obese at three years of age remained overweight or obese during adolescence [61]. For this group, the greatest acceleration in BMI standard deviation (SD) score occurred between two and six years of age. The analysis did not adjust for other known risk factors for obesity, such as parental weight or poverty. In a separate analysis from the same report, children who were large for gestational age at birth or whose mothers had obesity had particularly high risk for obesity, as has been shown in other studies. A separate long-term study found that obesity at age five years (compared with normal weight) was associated with higher BMI in mid-adulthood (mean BMI difference 6.5 kg/m2 at age 50) [54]. The tracking of obesity from age 5 to 50 years was modest (positive predictive value 67 percent). These studies demonstrate that excessive weight gain during the preschool years is a strong predictor of persistent obesity but do not determine whether the association is causal versus a marker of underlying inherent or environmental risk.

Studies with longer-term follow-up reveal that childhood obesity typically persists into adulthood, particularly for children with an obese parent. Among obese six-year-old children with an obese parent, 50 percent remained obese as adults, and among obese 10- to 14-year-old children with an obese parent, 80 percent remained obese as adults [16]. Similar findings were reported in a large international cohort in which 82 percent of individuals who were obese as children (age 11.4±4.0 years) remained obese as adults at follow-up approximately 23 years later [62]. A separate study used data from several large national datasets in the United States to simulate growth trajectories into adulthood and predicted that almost 60 percent of all United States children who are alive today will be obese by the time they reach 35 years of age [53]. The risk for adult obesity increases with age and childhood BMI. For children with severe obesity, tracking is strong and occurs early in life: A two year-old child with severe obesity has an 80 percent chance of being obese at age 35, while a five-year-old child with severe obesity has a 90 percent chance of remaining obese. These long-term studies must be interpreted with caution since the dietary habits and activity levels of today's children may differ from those of the children in the studies, thereby altering the risk of obesity in adulthood [63].

Most adolescents with obesity will continue to have obesity in adulthood. In a study of adolescents from a single city in the United States, obesity persisted into young adulthood in approximately two-thirds of adolescents, while one-third "exited" obesity [64]. The severity of obesity during adolescence is an important predictor of whether the obesity is likely to persist into adulthood [12,53]. In a large population study in the United States, approximately 75 percent of adolescents with severe obesity (BMI >120 percent of the 95th percentile) continued to have severe obesity as adults (BMI >40 kg/m2) [65]. Meanwhile, 8 percent of adolescents with more moderate obesity developed severe obesity as adults. In adolescents, the tracking of severe obesity is even stronger than in younger age groups [13].

Whether sex affects the risk that obesity will persist into adulthood varies markedly among studies in different populations. In one study from 1980, obesity during adolescence persisted into adulthood for approximately 80 percent of females but only 30 percent of males [66]. This was presumably related to changes in body composition that occur at puberty, when body fat decreases in males and increases in females [67]. However, in later cohorts, obesity in adolescent males is more likely to be persistent and the risk of persistent obesity is similar to that of females [68-70]. In one study from Australia, both males and females who had obesity during adolescence had a 50 to 60 percent chance of having obesity as young adults [70]. However, among adolescents who had overweight but not obesity during adolescence, males were more likely than females to have ongoing obesity during young adulthood (15 versus 12 percent).

Other risk factors for obesity in adulthood are discussed in greater detail separately. (See "Obesity in adults: Etiologies and risk factors".)

ETIOLOGY — The sections below summarize important factors that contribute to obesity in childhood and adolescence. The etiology and pathogenesis of obesity are discussed in greater detail separately. (See "Obesity in adults: Etiologies and risk factors" and "Obesity: Genetic contribution and pathophysiology".)

Environmental factors — Almost all obesity in children is strongly influenced by environmental factors, either a sedentary lifestyle or a caloric intake that is greater than needs. The contributions of specific environmental influences are the subject of considerable discussion and research. Environmental factors explain only part of obesity risk but are important targets for treatment because they are potentially modifiable [71,72].

Increasing trends in glycemic index of foods, sugar-containing beverages, portion sizes for prepared foods, and fast food service; diminishing family presence at meals; decreasing structured physical activity; increasing use of computer-, electronic-, and/or digital-oriented play activity; school meal nutrition content; and elements of the built environment (eg, availability of sidewalks and playgrounds) have all been considered as causal influences on the rise in obesity [72,73]. In particular, a number of well-designed studies have shown associations between intake of sugar-containing beverages or low physical activity and obesity or metabolic abnormalities [74-81]. Causal associations seem likely but are difficult to establish with certainty. Evidence supporting each of these factors is summarized in the sections below.

Sugar-sweetened beverages — Accumulating evidence suggests that consumption of sugar-sweetened beverages (including fruit juice) is an important contributor to the development of obesity in some individuals [82-84]. according to nationally representative surveys of children in the United States, sugar-sweetened beverages supplied an average of 270 kcal/day, representing 10 to 15 percent of total caloric intake [85]. Moreover, a randomized trial demonstrated that reducing consumption of sugar-sweetened beverages among adolescents with overweight and obesity was associated with a modest decrease in body mass index (BMI) [86]. In a separate randomized trial in 5- to 12-year-old children (primarily normal-weight), consumption of one serving of an artificially sweetened beverage daily was associated with less weight gain and fat accumulation as compared with consumption of a sugar-sweetened beverage [87].

In each of these studies, the observed effect sizes were small. Nonetheless, these findings support the concept that population-focused approaches to reduce intake of sugar-sweetened beverages, such as changes in school or public policy, including taxation, could be beneficial [88-92].

Recreational screen media use — Devices and format for screen media use continue to evolve, and all recreational (ie, not school-related) screen use should probably be considered together when setting goals for clinical purposes. One randomized study suggests that if a substantial reduction in screen media use can be achieved, it effectively increases physical activity [93].

Other studies associating screen time with obesity focused on specific types of media:

Television – Television viewing is perhaps the best-established environmental influence on the development of obesity during childhood. The amount of time spent watching television or the presence of a television in a child's bedroom are directly related to the prevalence of obesity in children and adolescents [94-100], although some other studies found only a weak correlation [101-103]. The effects may persist into adulthood: In two longitudinal cohort studies, television viewing at ≥5 years was independently associated with increased BMI at age 26 to 30 years [104,105].

Several mechanisms have been proposed to explain this association [106-109]:

Displacement of physical activity

Depression of metabolic rate

Adverse effects on diet quality (purported mechanism is that food consumption may not be appetite-driven in this setting, eg, prompted by food commercials)

Effects of television on sleep

One study provides evidence that the effects of television on obesity are mediated primarily by changes in energy intake. In a randomized trial, reducing television viewing and computer use among overweight four- to seven-year-old children was effective in reducing both BMI and energy intake during the two-year intervention, without apparent changes in physical activity [107]. Similar associations between television viewing and energy intake have been shown in studies of older or non-overweight youth [110].

Video games – The use of electronic games also has been associated with obesity during childhood [111,112]. The effect is small and may be mediated in part through increased consumption of sugar-sweetened beverages and irregular bedtimes [112]. In the few studies that analyze the influences separately, the association with obesity is somewhat weaker for electronic games than for television [98,111,113,114], perhaps because the games do not include food advertising.

Exergames – A few video games are designed to require interactive physical activity by the player; these are sometimes called "exergames" [115].

The efficacy of exergames to increase physical activity or treat obesity has not been systematically studied. A few studies suggest that they generally induce a small or moderate increase in energy expenditure during playing time [116-120]. As examples, two studies found that energy expenditure of playing some common sport-simulating exergames was higher than that of sedentary games but not as high as playing the sport itself [118,121]. The energy expenditure depends on the game: In one study, energy expenditure during six different activity-enhancing games ranged from 4.2 metabolic equivalents (mets) for Wii boxing to 7.1 mets for Sportwall, compared with 4.9 mets for walking at 3 miles/hour [122].

The long-term effect of activity-enhancing games probably depends on the intensity and participant enjoyment of the game, activities replaced by the gaming, and motivating support systems. One report described good patient retention and clinically significant reductions in BMI among adolescent patients participating in a multifaceted obesity management program, which featured one-hour group exergaming sessions or provision of exergame equipment for home use [123]. A systematic review of controlled trials of exergaming interventions reported mixed outcomes; 4 of 10 trials reported statistically significant beneficial effects on weight outcomes over 12 to 24 weeks [115].

Sleep — Mounting evidence suggests an association between shortened sleep duration or irregular sleep schedules and obesity. This association has been shown in multiple cross-sectional studies, after adjustment for a number of potential environmental confounders [73,124-128]. The effects are more marked in children at the upper end of the weight range [129]. Similar findings have been seen in adult populations [130]. Moreover, several longitudinal studies also showed associations after adjustment for confounders, suggesting that the association may be causal [131-140]. As an example, in a large longitudinal study among preschool-aged children with early bedtimes (8:00 PM or earlier), 10 percent developed obesity by adolescence, compared with 23 percent of those with late bedtimes (9:00 PM or later) [137]. Children with early bedtimes had a relative risk of adolescent obesity of 0.48 compared with late bedtimes, after adjustment for several confounding variables, including maternal obesity, maternal education, and income level. Additional support for a causal association comes from a short-term experimental study in which sleep deprivation for one week was associated with increased food intake, weight gain, and higher leptin levels as compared with the child's usual sleep [141]. Behavioral strategies for improving sleep in children are discussed in a separate topic review. (See "Behavioral sleep problems in children".)

Sleep may have an association with insulin resistance and cardiometabolic risk factors, independent of its association with obesity. In several studies of adolescents with obesity and sleep-disordered breathing, sleep fragmentation and intermittent hypoxemia were associated with decreased insulin sensitivity, independent of adiposity [128,142-145]. Similarly, shorter sleep duration was associated with markers of cardiometabolic risk factors, including abdominal obesity, increased blood pressure, and abnormal lipid profile [146].

The mechanism for an association between sleep duration and obesity has not been established but may include alterations in serum leptin and ghrelin levels, both of which have been implicated in the regulation of appetite. Sleep deprivation is also associated with increased neural reward processing, which may lead to increased food intake in susceptible individuals [147]. Alternatively, short sleep duration may be associated with reduced physical activity levels and/or provide a longer opportunity to ingest food. (See "Obesity in adults: Etiologies and risk factors", section on 'Sleep patterns'.)

Medications — A number of drugs can cause weight gain, including certain psychoactive drugs (particularly olanzapine and risperidone), antiseizure medication, and glucocorticoids (table 3). Weight gain and hyperlipidemia induced by olanzapine may be particularly severe in adolescents as compared with adults [148]. Brief courses of oral or inhaled glucocorticoids (eg, several days for an exacerbation of asthma) are unlikely to have long-term effects on body weight unless they are prescribed frequently. Medication-induced weight gain is discussed separately. (See "Obesity in adults: Etiologies and risk factors", section on 'Medications associated with weight gain' and "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Endocrinologic and metabolic side effects' and "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Metabolic dysregulation'.)

Other — Other environmental factors that have been proposed as possible contributors to obesity include the influences of gut microbiota, environmental toxins, and viruses. The role of each of these factors remains speculative but is supported by preliminary evidence and is the subject of ongoing investigation.

Gut microbiome – Several lines of investigation have suggested that there is a relationship between the gut microbiome and the potential for weight gain [149-151]. Several observational studies have suggested an association between obesity and exposure to antibiotics (or maternal infection) during gestation [152-155] or infancy [152,156-161]. Contrasting results were seen in another large study, which found no such association including in a secondary analysis of twin pairs [162]. If there is an association, the effect size appears to be small and may not be clinically important.

Studies in animal models generally support the possibility of an association between the gut microbiome and weight gain or loss. These include studies on antibiotic exposure [163,164] and models of gastric bypass surgery [165-167].

Toxins – Epidemiologic studies raise the possibility that obesity could be triggered or exacerbated by exposure to environmental endocrine-disrupting chemicals, such as the pesticide dichlorodiphenyltrichloroethane (DDT) [168] or bisphenol A (BPA). BPA is a compound used to manufacture polycarbonate resin and is a common contaminant of foods sold in cans and plastic packaging [169]. Most individuals in the United States have detectable levels of BPA in urine, and most of the exposure is from food [170]. Experimental studies in cell culture and animals suggest that BPA is a selective modulator of estrogen receptors and accelerates adipogenesis and postnatal somatic growth [171-173]. Epidemiologic studies in adults and children demonstrate an association between urinary BPA concentrations and obesity or obesity-related diseases, including diabetes and cardiovascular disease [174-177]. It is possible that the observed association is due to dietary or environmental variables that were not included in the analysis, or by increased storage of BPA in adipose tissue among obese individuals, rather than a direct causal effect. (See "Endocrine-disrupting chemicals".)

Exposure to such endocrine-disrupting chemicals could also be a mechanism for the "metabolic programming" phenomenon described below. (See 'Metabolic programming' below.)

Viruses – A few studies suggest the possibility that obesity can be triggered or exacerbated by exposure to a virus. Adenovirus 36 increases body fat in several animal models, and human studies have found conflicting results about an association between the presence of this serotype and obesity. These data are discussed in a separate topic review. (See "Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Possible association with obesity'.)

Genetic factors

Polygenic factors – There is strong evidence that genetic factors play a permissive role and interact with environmental factors to produce obesity. Studies suggest that heritable factors are responsible for 40 to 85 percent of the variation in adiposity [178], but most of the genetic polymorphisms responsible have not yet been isolated. Thus, genetic contributions to common obesity likely exist, but most of the molecular mechanisms for these factors have yet to be determined. Moreover, genetic and environmental factors interact, such that a healthy home environment can attenuate the effect of genetic factors. In a large study of twin pairs, the heritability of BMI was greater among children living in obesogenic home environments compared with those living in healthier environments during early childhood [179]. (See "Obesity: Genetic contribution and pathophysiology", section on 'Common (multifactorial) obesity'.)

Syndromic obesity – A variety of specific syndromes in which obesity is a primary manifestation have been identified (table 4). These are rare causes of obesity, accounting for less than one percent of childhood obesity in tertiary care centers [24,180,181]. Obesity is also a component of several relatively common genetic syndromes, including Down syndrome.

In addition to being overweight, children with genetic syndromes associated with obesity typically have early-onset obesity and characteristic findings on physical examination. These include dysmorphic features, short stature, developmental delay, intellectual disability, retinal changes, or deafness. Prader-Willi is the most common of these syndromes and is characterized by hypotonia and feeding difficulties during infancy (often with failure to thrive), with hyperphagia and obesity developing during early childhood, with developmental delay. For most of the syndromes, including Prader-Willi and Bardet-Biedl syndromes, the genetic cause has been sufficiently isolated to permit specific testing, but the exact mechanism through which they cause obesity is not understood or is attributable to multiple genes (table 4). (See "Prader-Willi syndrome: Management".)

Monogenic obesity – Single-gene defects in which obesity is the primary manifestation are even more rare (table 5). Several of these affect the melanocortin pathway in the central nervous system. Melanocortin 4 receptor defects (MIM *155541) are the most common but are still rare, contributing to obesity in approximately 2 to 6 percent of individuals with early-onset obesity [182-185]. Mutations causing deficiencies in leptin (MIM #614692) or its receptor (MIM #614963) are rare and usually are associated with consanguinity [186-188]. (See "Obesity: Genetic contribution and pathophysiology", section on 'Monogenic forms of obesity'.)

Endocrine disorders — Endocrine causes of weight gain are identified in less than 1 percent of children and adolescents with obesity [181,189]. These disorders usually are associated with overweight or mild obesity rather than severe obesity (table 6). Most children with these problems have short stature and/or hypogonadism [181]. The primary considerations are:

Cortisol excess (eg, the use of corticosteroid medication, Cushing syndrome) (see "Epidemiology and clinical manifestations of Cushing syndrome")

Hypothyroidism (see "Acquired hypothyroidism in childhood and adolescence")

Growth hormone deficiency (see "Diagnosis of growth hormone deficiency in children")

Pseudohypoparathyroidism type 1a (Albright hereditary osteodystrophy) (see "Etiology of hypocalcemia in infants and children", section on 'End-organ resistance to PTH (pseudohypoparathyroidism)')

Hypothalamic obesity — Hypothalamic lesions may cause rapidly progressive severe obesity, which is particularly difficult to treat (table 6). In the pediatric age group, hypothalamic obesity most often arises after surgical treatment for craniopharyngioma and usually is associated with panhypopituitarism. Similar patterns may be caused by trauma, tumor, or an inflammatory disease affecting the hypothalamus. (See "Craniopharyngioma" and "Obesity in adults: Etiologies and risk factors", section on 'Hypothalamic obesity'.)

A rare cause of hypothalamic obesity is a syndrome consisting of rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD), which may be associated with neuroendocrine tumors, leading to the expanded acronym, ROHHADNET. Patients may present in infancy or early childhood with central hypoventilation (resembling congenital central hypoventilation syndrome) and a variety of abnormalities in the hypothalamic-pituitary axis, with autonomic dysregulation, including episodes of hyperthermia or hypothermia (table 7) [190,191]. (See "Congenital central hypoventilation syndrome and other causes of sleep-related hypoventilation in children", section on 'Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD)'.)

Metabolic programming — There is increasing evidence that environmental and nutritional influences during critical periods in development can have permanent effects on an individual's predisposition to obesity and metabolic disease. The precise mediators and mechanisms for these effects have not been established but are the subject of ongoing investigations [192,193]. This phenomenon has been called "metabolic programming" and may account for a component of intergenerational transmission of obesity via epigenetic mechanisms (see "Principles of epigenetics"), in addition to genetic and environmental factors. The best evidence for metabolic programming focuses on gestation. There is modest information about effects during infancy and early childhood and minimal information about any effects during later life stages. Examples of the evidence supporting metabolic programming of body weight are provided in the following sections.

Gestation — Maternal body weight and nutritional factors during gestation are probably an important determinant of metabolic programming. Several key areas demonstrate the link between the intrauterine environment and child health and weight:

Effect of maternal nutrition during pregnancy – During the Dutch famine of 1944 to 1945, exposure to famine during early gestation (first trimester) was associated with obesity, metabolic disease, and cardiovascular mortality and overall mortality [194-198], while exposure to famine at any stage of gestation was associated with higher rates of insulin resistance [199,200].

Effect of maternal prepregnancy weight – Some studies suggest that a mother's prepregnancy weight and weight gain during pregnancy are predictors of the child's birth weight and/or weight during childhood [201], and the association persists after adjusting for genetic and other prenatal environmental factors [202-207]. However, another large study found a minimal effect of incremental increases in maternal BMI during pregnancy on offspring BMI during childhood, after rigorous adjustment for genetic factors [208]. (See "Gestational weight gain".)

The possibility of a causal relationship between the intrauterine environment and obesity in the offspring is supported by studies in women who have had gastric bypass surgery: Children born to women who have had gastric bypass surgery appear to have a lower prevalence of obesity than those born before the gastric bypass, suggesting that reversal of maternal obesity had beneficial long-term effects on the metabolic profile of the offspring [209]. In contrast, a separate study was unable to detect an effect of maternal BMI on metabolic programming in the offspring: Mother-offspring associations for BMI were equally as strong as the father-offspring association, suggesting that the effect was not mediated through the intrauterine environment [210]. Thus, the mechanism involved in the intergenerational transmission of obesity is complex and/or difficult to detect in clinical studies in humans.

Association of birth weight with long-term metabolic outcomes – Individuals born small for gestational age, large for gestational age, or prematurely have higher rates of insulin resistance during childhood and young adulthood, even after controlling for obesity status [202,211-213], as well as associations between birth weight (reflecting fetal nutrition) and later diabetes, heart disease, insulin resistance, and obesity [214-218].

Association with other maternal endocrine factors – Other markers of the maternal endocrine milieu are also associated with childhood obesity, although the mechanisms for the association are not established, as illustrated by the following studies:

Maternal diabetes mellitus during gestation is associated with an increased BMI in adult male offspring, independent of maternal BMI in early pregnancy [219].

Maternal preeclampsia, with or without prematurity, is associated with higher BMI in the offspring by adolescence [220,221]. Studies conflict in their results as to whether this association is limited to male [221,222] or female offspring [223].

Infancy and early childhood — Infancy and early childhood may also be critical periods for metabolic programming. Studies in a variety of populations have shown consistent associations between rates of weight gain during infancy or early childhood and subsequent obesity or metabolic syndrome during early childhood [224-226], adolescence, or adulthood [227] (for systematic reviews, see references [228-231]), or with intermediate outcomes such as adiposity, blood pressure, and other cardiovascular risk factors in early childhood [232-235].

In particular, some (but not all) studies suggest that breastfeeding has a protective effect against childhood obesity, as detailed in a separate topic review (see "Infant benefits of breastfeeding", section on 'Limited evidence for benefit'). Other studies suggest that this effect may be mediated by protein intake since high protein intakes during the first two years of life appear to promote weight gain (although not necessarily adiposity) [236-238]. In a randomized trial, formulas with standard concentrations of protein (11.7 percent of energy for infant formula and 17.6 percent of energy for follow-on formula) were associated with higher BMI at school age compared with formulas with lower concentrations of protein that are similar to breast milk (7.1 percent of energy for infant formula) [236,237]. It should be noted that these studies did not determine whether the difference in weight was attributable to adipose versus lean mass.

Clinical implications — The above evidence describing metabolic programming during gestation and early life suggest that early intervention might be an important tool in preventing obesity.

Controlled trials of early nutritional interventions with long-term outcomes are still lacking. Nonetheless, there is ample circumstantial evidence to support clinical efforts to optimize nutrition during gestation, infancy, and early childhood. Appropriate goals are to optimize glycemic control in pregnant women and target moderate rates of weight gain in infants and young children. Breastfeeding may have a protective effect on the later development of obesity, in addition to its many other benefits to the infant. The effect appears to be small, and the mechanism of the association is unclear. (See "Infant benefits of breastfeeding", section on 'Chronic disease' and "Prevention and management of childhood obesity in the primary care setting", section on 'Prevention'.)

Nutritional goals are less clear for low birth weight infants, for whom catch-up growth is associated with improved neurodevelopmental outcomes but also with increased risks for metabolic disease [239-242]. Increasing the protein component of feeding (eg, a maximum protein content of 3.6 g/100 kcals) appears to improve growth and metabolic health, including normalizing serum insulin-like growth factor 1 (IGF-1) concentrations [239]. This strategy has been proposed to achieve improved neurodevelopmental and metabolic outcomes for these infants, but it is not yet tested. (See "Nutritional composition of human milk and preterm formula for the premature infant", section on 'Protein'.)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Obesity in children".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topic (see "Patient education: Weight and health in children (The Basics)")

SUMMARY

Body mass index (BMI) – BMI is the accepted standard measure of overweight and obesity for children two years of age and older. BMI provides a guideline for weight in relation to height and is equal to the body weight (in kilograms) divided by the height (in meters) squared (table 1). Reference standards vary by age and sex (figure 1A-B). (See 'Definitions' above.)

Weight categories – For children between 2 and 20 years of age, the following weight categories are used (table 2) (see 'Definitions' above):

Overweight – BMI between the 85th and 95th percentile for age and sex.

Obesity – Classified by severity, using the following thresholds ( (figure 2A-B) or CDC extended BMI growth charts):

-Class I: BMI ≥95th percentile for age and sex or BMI ≥30 (whichever is lower)

-Class II: BMI ≥120 percent of the 95th percentile values or BMI ≥35 (whichever is lower)

-Class III: BMI ≥140 percent of the 95th percentile values or BMI ≥40 kg/m2 (whichever is lower)

Epidemiology

Prevalence – Approximately one-third of children and adolescents in the United States are either overweight or obese (figure 3). The prevalence of obesity among children and adolescents tripled from the late 1970s to 2000 and subsequently plateaued for most age and weight categories, although the prevalence of severe obesity continues to increase (figure 4). Several regions or subpopulations have shown slight decreases in childhood obesity since 2008. The prevalence of childhood overweight and obesity also increased in many other resource-abundant countries worldwide (figure 5). (See 'Prevalence' above.)

Tracking – The likelihood of persistence of childhood obesity into adulthood is related to age, parental obesity, and severity of obesity. A substantial component of adolescent obesity is established before five years of age. (See 'Persistence into adulthood' above.)

Etiology of obesity

Environmental factors – Factors that contribute to obesity include increasing trends in glycemic index of foods, sugar-containing beverages, larger portion sizes for prepared foods, fast food service, diminishing family presence at meals, decreasing structured physical activity, increased sedentary activities (eg, screen time), shortened sleep duration, and changes in elements of the built environment (eg, availability of sidewalks and playgrounds). For a few children, medications (eg, certain psychoactive drugs) have an important causal role. (See 'Environmental factors' above and 'Medications' above.)

Genetic factors – Genetic factors play a permissive role and interact with environmental factors to produce obesity. Studies suggest that heritable factors are responsible for 40 to 85 percent of the variation in adiposity, but most of the genetic polymorphisms responsible have not yet been isolated. A few specific syndromes and single-gene defects which are linked to obesity in childhood have been identified (table 4 and table 5). (See 'Genetic factors' above.)

Endocrine causes – Endocrine disorders are identified in less than 1 percent of children and adolescents with obesity. The disorders include hypothyroidism, cortisol excess (eg, the use of corticosteroid medication, Cushing syndrome), growth hormone deficiency, and pseudohypoparathyroidism. Most children with these problems have short stature and/or hypogonadism (table 6). (See 'Endocrine disorders' above.)

Hypothalamic obesity – Hypothalamic lesions tend to cause rapidly progressive severe obesity, which is particularly difficult to treat. In the pediatric age group, hypothalamic obesity most often arises after surgical treatment for craniopharyngioma and usually is associated with panhypopituitarism. Similar patterns may be caused by trauma, tumor, or an inflammatory disease affecting the hypothalamus. (See 'Hypothalamic obesity' above.)

Metabolic programming – Metabolic programming refers to the concept that environmental and nutritional influences during critical periods in development, particularly during gestation, can have permanent effects on an individual's predisposition to obesity and metabolic disease. (See 'Metabolic programming' above.)

  1. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001; 286:2845.
  2. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017; 377:13.
  3. Ogden CL, Fryar CD, Martin CB, et al. Trends in Obesity Prevalence by Race and Hispanic Origin-1999-2000 to 2017-2018. JAMA 2020; 324:1208.
  4. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics 2023; 151.
  5. Styne DM, Arslanian SA, Connor EL, et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102:709.
  6. NICE: Obesity: identification, assessment and management, updated 2022. Available at: https://www.nice.org.uk/guidance/cg189/chapter/Recommendations#identifying-and-assessing-overweight-obesity-and-central-adiposity (Accessed on January 11, 2023).
  7. Skinner AC, Ravanbakht SN, Skelton JA, et al. Prevalence of Obesity and Severe Obesity in US Children, 1999-2016. Pediatrics 2018; 141.
  8. Centers for Disease Control and Prevention. CDC extended BMI-for-age growth charts. 2022. Available at: https://www.cdc.gov/growthcharts/extended-bmi.htm (Accessed on January 11, 2023).
  9. Ogden CL, Freedman DS, Hales CM. CDC Extended BMI-for-Age Percentiles Versus Percent of the 95th Percentile. Pediatrics 2023; 152.
  10. Freedman DS, Butte NF, Taveras EM, et al. The Limitations of Transforming Very High Body Mass Indexes into z-Scores among 8.7 Million 2- to 4-Year-Old Children. J Pediatr 2017; 188:50.
  11. Freedman DS, Butte NF, Taveras EM, et al. BMI z-Scores are a poor indicator of adiposity among 2- to 19-year-olds with very high BMIs, NHANES 1999-2000 to 2013-2014. Obesity (Silver Spring) 2017; 25:739.
  12. Kelly AS, Barlow SE, Rao G, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation 2013; 128:1689.
  13. Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 2007; 150:12.
  14. Bomberg EM, Addo OY, Sarafoglou K, Miller BS. Adjusting for Pubertal Status Reduces Overweight and Obesity Prevalence in the United States. J Pediatr 2021; 231:200.
  15. Ogden CL, Fryar CD, Hales CM, et al. Differences in Obesity Prevalence by Demographics and Urbanization in US Children and Adolescents, 2013-2016. JAMA 2018; 319:2410.
  16. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337:869.
  17. Eagle TF, Sheetz A, Gurm R, et al. Understanding childhood obesity in America: linkages between household income, community resources, and children's behaviors. Am Heart J 2012; 163:836.
  18. Pan L, Blanck HM, Sherry B, et al. Trends in the prevalence of extreme obesity among US preschool-aged children living in low-income families, 1998-2010. JAMA 2012; 308:2563.
  19. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017; 390:2627.
  20. Neovius M, Linné Y, Barkeling B, Rössner S. Discrepancies between classification systems of childhood obesity. Obes Rev 2004; 5:105.
  21. Wang Y. Cross-national comparison of childhood obesity: the epidemic and the relationship between obesity and socioeconomic status. Int J Epidemiol 2001; 30:1129.
  22. Janssen I, Katzmarzyk PT, Boyce WF, et al. Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev 2005; 6:123.
  23. World Obesity Federation, World Map of Obesity. Available at: http://www.worldobesity.org/aboutobesity/world-map-obesity/?map=children (Accessed on May 05, 2015).
  24. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728.
  25. Ogden CL, Carroll MD, Lawman HG, et al. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. JAMA 2016; 315:2292.
  26. Pan L, Blanck HM, Park S, et al. State-Specific Prevalence of Obesity Among Children Aged 2-4 Years Enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children - United States, 2010-2016. MMWR Morb Mortal Wkly Rep 2019; 68:1057.
  27. Pan L, Freedman DS, Park S, et al. Changes in Obesity Among US Children Aged 2 Through 4 Years Enrolled in WIC During 2010-2016. JAMA 2019; 321:2364.
  28. Kern E, Chan NL, Fleming DW, et al. Declines in student obesity prevalence associated with a prevention initiative - King County, Washington, 2012. MMWR Morb Mortal Wkly Rep 2014; 63:155.
  29. Wen X, Gillman MW, Rifas-Shiman SL, et al. Decreasing prevalence of obesity among young children in Massachusetts from 2004 to 2008. Pediatrics 2012; 129:823.
  30. Centers for Disease Control and Prevention (CDC). Obesity in K-8 students - New York City, 2006-07 to 2010-11 school years. MMWR Morb Mortal Wkly Rep 2011; 60:1673.
  31. Centers for Disease Control and Prevention (CDC). Obesity prevalence among low-income, preschool-aged children--New York City and Los Angeles County, 2003-2011. MMWR Morb Mortal Wkly Rep 2013; 62:17.
  32. Centers for Disease Control and Prevention (CDC). Obesity in K-7 students - Anchorage, Alaska, 2003-04 to 2010-11 school years. MMWR Morb Mortal Wkly Rep 2013; 62:426.
  33. Gluckman P, Nishtar S, Armstrong T. Ending childhood obesity: a multidimensional challenge. Lancet 2015; 385:1048.
  34. World Health Organization. Obesity and overweight, Fact sheet #311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ (Accessed on March 26, 2015).
  35. Huse O, Hettiarachchi J, Gearon E, et al. Obesity in Australia. Obes Res Clin Pract 2018; 12:29.
  36. Salanave B, Peneau S, Rolland-Cachera MF, et al. Stabilization of overweight prevalence in French children between 2000 and 2007. Int J Pediatr Obes 2009; 4:66.
  37. Keß A, Spielau U, Beger C, et al. Further stabilization and even decrease in the prevalence rates of overweight and obesity in German children and adolescents from 2005 to 2015: a cross-sectional and trend analysis. Public Health Nutr 2017; 20:3075.
  38. Aeberli I, Ammann RS, Knabenhans M, et al. Decrease in the prevalence of paediatric adiposity in Switzerland from 2002 to 2007. Public Health Nutr 2010; 13:806.
  39. de Bont J, Díaz Y, Casas M, et al. Time Trends and Sociodemographic Factors Associated With Overweight and Obesity in Children and Adolescents in Spain. JAMA Netw Open 2020; 3:e201171.
  40. Rodd C, Sharma AK. Recent trends in the prevalence of overweight and obesity among Canadian children. CMAJ 2016; 188:E313.
  41. Daniels L, Taylor BJ, Taylor RW, et al. Further reductions in the prevalence of obesity in 4-year-old New Zealand children from 2017 to 2019. Int J Obes (Lond) 2022; 46:1176.
  42. Maessen SE, Nichols M, Cutfield W, et al. High but decreasing prevalence of overweight in preschool children: encouragement for further action. BMJ 2023; 383:e075736.
  43. Woolford SJ, Sidell M, Li X, et al. Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic. JAMA 2021; 326:1434.
  44. Qiu N, He H, Qiao L, et al. Sex differences in changes in BMI and blood pressure in Chinese school-aged children during the COVID-19 quarantine. Int J Obes (Lond) 2021; 45:2132.
  45. Vogel M, Geserick M, Gausche R, et al. Age- and weight group-specific weight gain patterns in children and adolescents during the 15 years before and during the COVID-19 pandemic. Int J Obes (Lond) 2022; 46:144.
  46. Knapp EA, Dong Y, Dunlop AL, et al. Changes in BMI During the COVID-19 Pandemic. Pediatrics 2022; 150.
  47. Lange SJ, Kompaniyets L, Freedman DS, et al. Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2-19 Years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep 2021; 70:1278.
  48. Jenssen BP, Kelly MK, Powell M, et al. COVID-19 and Changes in Child Obesity. Pediatrics 2021; 147.
  49. Chung A, Tully L, Czernin S, et al. Reducing risk of childhood obesity in the wake of covid-19. BMJ 2021; 374:n1716.
  50. Guo SS, Roche AF, Chumlea WC, et al. The predictive value of childhood body mass index values for overweight at age 35 y. Am J Clin Nutr 1994; 59:810.
  51. Power C, Lake JK, Cole TJ. Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am J Clin Nutr 1997; 66:1094.
  52. Parsons TJ, Power C, Logan S, Summerbell CD. Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord 1999; 23 Suppl 8:S1.
  53. Ward ZJ, Long MW, Resch SC, et al. Simulation of Growth Trajectories of Childhood Obesity into Adulthood. N Engl J Med 2017; 377:2145.
  54. Rundle AG, Factor-Litvak P, Suglia SF, et al. Tracking of Obesity in Childhood into Adulthood: Effects on Body Mass Index and Fat Mass Index at Age 50. Child Obes 2020; 16:226.
  55. Rudolf M. Predicting babies' risk of obesity. Arch Dis Child 2011; 96:995.
  56. Nielsen J, Hulman A, Narayan KMV, Cunningham SA. Body Mass Index Trajectories From Childhood to Adulthood and Age at Onset of Overweight and Obesity: The Influence of Parents' Weight Status. Am J Epidemiol 2022; 191:1877.
  57. Power C, Lake JK, Cole TJ. Measurement and long-term health risks of child and adolescent fatness. Int J Obes Relat Metab Disord 1997; 21:507.
  58. Cunningham SA, Kramer MR, Narayan KM. Incidence of childhood obesity in the United States. N Engl J Med 2014; 370:403.
  59. Mead E, Batterham AM, Atkinson G, Ells LJ. Predicting future weight status from measurements made in early childhood: a novel longitudinal approach applied to Millennium Cohort Study data. Nutr Diabetes 2016; 6:e200.
  60. Buscot MJ, Thomson RJ, Juonala M, et al. BMI Trajectories Associated With Resolution of Elevated Youth BMI and Incident Adult Obesity. Pediatrics 2018; 141.
  61. Geserick M, Vogel M, Gausche R, et al. Acceleration of BMI in Early Childhood and Risk of Sustained Obesity. N Engl J Med 2018; 379:1303.
  62. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011; 365:1876.
  63. Johnson W, Bann D, Hardy R. Infant weight gain and adolescent body mass index: comparison across two British cohorts born in 1946 and 2001. Arch Dis Child 2018; 103:974.
  64. Watts AW, Loth KA, Peterson C, et al. Characteristics of a Favorable Weight Status Change From Adolescence to Young Adulthood. J Adolesc Health 2016; 58:403.
  65. The NS, Suchindran C, North KE, et al. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010; 304:2042.
  66. Garn SM, Cole PE. Do the obese remain obese and the lean remain lean? Am J Public Health 1980; 70:351.
  67. Mellits ED, Cheek DB. The assessment of body water and fatness from infancy to adulthood. Monogr Soc Res Child Dev 1970; 35:12.
  68. Deshmukh-Taskar P, Nicklas TA, Morales M, et al. Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study. Eur J Clin Nutr 2006; 60:48.
  69. Herman KM, Craig CL, Gauvin L, Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: the Physical Activity Longitudinal Study. Int J Pediatr Obes 2009; 4:281.
  70. Patton GC, Coffey C, Carlin JB, et al. Overweight and obesity between adolescence and young adulthood: a 10-year prospective cohort study. J Adolesc Health 2011; 48:275.
  71. Plachta-Danielzik S, Kehden B, Landsberg B, et al. Attributable risks for childhood overweight: evidence for limited effectiveness of prevention. Pediatrics 2012; 130:e865.
  72. Taber DR, Chriqui JF, Powell L, Chaloupka FJ. Association between state laws governing school meal nutrition content and student weight status: implications for new USDA school meal standards. JAMA Pediatr 2013; 167:513.
  73. Anderson SE, Whitaker RC. Household routines and obesity in US preschool-aged children. Pediatrics 2010; 125:420.
  74. Bremer AA, Auinger P, Byrd RS. Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999-2004 National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2009; 163:328.
  75. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006; 84:274.
  76. Berkey CS, Rockett HR, Field AE, et al. Sugar-added beverages and adolescent weight change. Obes Res 2004; 12:778.
  77. Ebbeling CB, Feldman HA, Osganian SK, et al. Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics 2006; 117:673.
  78. Dowda M, Ainsworth BE, Addy CL, et al. Environmental influences, physical activity, and weight status in 8- to 16-year-olds. Arch Pediatr Adolesc Med 2001; 155:711.
  79. Menschik D, Ahmed S, Alexander MH, Blum RW. Adolescent physical activities as predictors of young adult weight. Arch Pediatr Adolesc Med 2008; 162:29.
  80. Levin S, Lowry R, Brown DR, Dietz WH. Physical activity and body mass index among US adolescents: youth risk behavior survey, 1999. Arch Pediatr Adolesc Med 2003; 157:816.
  81. Drake KM, Beach ML, Longacre MR, et al. Influence of sports, physical education, and active commuting to school on adolescent weight status. Pediatrics 2012; 130:e296.
  82. Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 2013; 98:1084.
  83. DeBoer MD, Scharf RJ, Demmer RT. Sugar-sweetened beverages and weight gain in 2- to 5-year-old children. Pediatrics 2013; 132:413.
  84. Hu H, Song J, MacGregor GA, He FJ. Consumption of Soft Drinks and Overweight and Obesity Among Adolescents in 107 Countries and Regions. JAMA Netw Open 2023; 6:e2325158.
  85. Wang YC, Bleich SN, Gortmaker SL. Increasing caloric contribution from sugar-sweetened beverages and 100% fruit juices among US children and adolescents, 1988-2004. Pediatrics 2008; 121:e1604.
  86. Ebbeling CB, Feldman HA, Chomitz VR, et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med 2012; 367:1407.
  87. de Ruyter JC, Olthof MR, Seidell JC, Katan MB. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med 2012; 367:1397.
  88. Farley TA. The role of government in preventing excess calorie consumption: the example of New York City. JAMA 2012; 308:1093.
  89. Elbel B, Cantor J, Mijanovich T. Potential effect of the New York City policy regarding sugared beverages. N Engl J Med 2012; 367:680.
  90. Turner L, Chaloupka FJ. Encouraging trends in student access to competitive beverages in US public elementary schools, 2006-2007 to 2010-2011. Arch Pediatr Adolesc Med 2012; 166:673.
  91. Pomeranz JL, Brownell KD. Portion sizes and beyond--government's legal authority to regulate food-industry practices. N Engl J Med 2012; 367:1383.
  92. Briggs AD, Mytton OT, Kehlbacher A, et al. Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study. BMJ 2013; 347:f6189.
  93. Pedersen J, Rasmussen MGB, Sørensen SO, et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr 2022; 176:741.
  94. Dietz WH Jr, Gortmaker SL. Do we fatten our children at the television set? Obesity and television viewing in children and adolescents. Pediatrics 1985; 75:807.
  95. Kaur H, Choi WS, Mayo MS, Harris KJ. Duration of television watching is associated with increased body mass index. J Pediatr 2003; 143:506.
  96. Berkey CS, Rockett HR, Gillman MW, Colditz GA. One-year changes in activity and in inactivity among 10- to 15-year-old boys and girls: relationship to change in body mass index. Pediatrics 2003; 111:836.
  97. Braithwaite I, Stewart AW, Hancox RJ, et al. The worldwide association between television viewing and obesity in children and adolescents: cross sectional study. PLoS One 2013; 8:e74263.
  98. Falbe J, Rosner B, Willett WC, et al. Adiposity and different types of screen time. Pediatrics 2013; 132:e1497.
  99. Gilbert-Diamond D, Li Z, Adachi-Mejia AM, et al. Association of a television in the bedroom with increased adiposity gain in a nationally representative sample of children and adolescents. JAMA Pediatr 2014; 168:427.
  100. Heilmann A, Rouxel P, Fitzsimons E, et al. Longitudinal associations between television in the bedroom and body fatness in a UK cohort study. Int J Obes (Lond) 2017; 41:1503.
  101. Marshall SJ, Biddle SJ, Gorely T, et al. Relationships between media use, body fatness and physical activity in children and youth: a meta-analysis. Int J Obes Relat Metab Disord 2004; 28:1238.
  102. Wake M, Hesketh K, Waters E. Television, computer use and body mass index in Australian primary school children. J Paediatr Child Health 2003; 39:130.
  103. Wahi G, Parkin PC, Beyene J, et al. Effectiveness of interventions aimed at reducing screen time in children: a systematic review and meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med 2011; 165:979.
  104. Hancox RJ, Milne BJ, Poulton R. Association between child and adolescent television viewing and adult health: a longitudinal birth cohort study. Lancet 2004; 364:257.
  105. Viner RM, Cole TJ. Television viewing in early childhood predicts adult body mass index. J Pediatr 2005; 147:429.
  106. Ludwig DS, Gortmaker SL. Programming obesity in childhood. Lancet 2004; 364:226.
  107. Epstein LH, Roemmich JN, Robinson JL, et al. A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children. Arch Pediatr Adolesc Med 2008; 162:239.
  108. Boyland EJ, Harrold JA, Kirkham TC, et al. Food commercials increase preference for energy-dense foods, particularly in children who watch more television. Pediatrics 2011; 128:e93.
  109. Lipsky LM, Iannotti RJ. Associations of television viewing with eating behaviors in the 2009 Health Behaviour in School-aged Children Study. Arch Pediatr Adolesc Med 2012; 166:465.
  110. Epstein LH, Roemmich JN, Paluch RA, Raynor HA. Influence of changes in sedentary behavior on energy and macronutrient intake in youth. Am J Clin Nutr 2005; 81:361.
  111. Stettler N, Signer TM, Suter PM. Electronic games and environmental factors associated with childhood obesity in Switzerland. Obes Res 2004; 12:896.
  112. Goodman W, Jackson SE, McFerran E, et al. Association of Video Game Use With Body Mass Index and Other Energy-Balance Behaviors in Children. JAMA Pediatr 2020; 174:563.
  113. Kautiainen S, Koivusilta L, Lintonen T, et al. Use of information and communication technology and prevalence of overweight and obesity among adolescents. Int J Obes (Lond) 2005; 29:925.
  114. Bickham DS, Blood EA, Walls CE, et al. Characteristics of screen media use associated with higher BMI in young adolescents. Pediatrics 2013; 131:935.
  115. Valeriani F, Protano C, Marotta D, et al. Exergames in Childhood Obesity Treatment: A Systematic Review. Int J Environ Res Public Health 2021; 18.
  116. Lanningham-Foster L, Jensen TB, Foster RC, et al. Energy expenditure of sedentary screen time compared with active screen time for children. Pediatrics 2006; 118:e1831.
  117. Mellecker RR, McManus AM. Energy expenditure and cardiovascular responses to seated and active gaming in children. Arch Pediatr Adolesc Med 2008; 162:886.
  118. Graf DL, Pratt LV, Hester CN, Short KR. Playing active video games increases energy expenditure in children. Pediatrics 2009; 124:534.
  119. Biddiss E, Irwin J. Active video games to promote physical activity in children and youth: a systematic review. Arch Pediatr Adolesc Med 2010; 164:664.
  120. O'Loughlin EK, Dugas EN, Sabiston CM, O'Loughlin JL. Prevalence and correlates of exergaming in youth. Pediatrics 2012; 130:806.
  121. Graves L, Stratton G, Ridgers ND, Cable NT. Comparison of energy expenditure in adolescents when playing new generation and sedentary computer games: cross sectional study. BMJ 2007; 335:1282.
  122. Bailey BW, McInnis K. Energy cost of exergaming: a comparison of the energy cost of 6 forms of exergaming. Arch Pediatr Adolesc Med 2011; 165:597.
  123. Trost SG, Sundal D, Foster GD, et al. Effects of a pediatric weight management program with and without active video games a randomized trial. JAMA Pediatr 2014; 168:407.
  124. Jiang F, Zhu S, Yan C, et al. Sleep and obesity in preschool children. J Pediatr 2009; 154:814.
  125. Altenburg TM, Chinapaw MJ, van der Knaap ET, et al. Longer sleep--slimmer kids: the ENERGY-project. PLoS One 2013; 8:e59522.
  126. Collings PJ, Ball HL, Santorelli G, et al. Sleep Duration and Adiposity in Early Childhood: Evidence for Bidirectional Associations from the Born in Bradford Study. Sleep 2017; 40.
  127. Gariépy G, Janssen I, Sentenac M, Elgar FJ. School Start Time and the Healthy Weight of Adolescents. J Adolesc Health 2018; 63:69.
  128. Cespedes Feliciano EM, Rifas-Shiman SL, Quante M, et al. Chronotype, Social Jet Lag, and Cardiometabolic Risk Factors in Early Adolescence. JAMA Pediatr 2019; 173:1049.
  129. Bayer O, Rosario AS, Wabitsch M, von Kries R. Sleep duration and obesity in children: is the association dependent on age and choice of the outcome parameter? Sleep 2009; 32:1183.
  130. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008; 31:619.
  131. Landhuis CE, Poulton R, Welch D, Hancox RJ. Childhood sleep time and long-term risk for obesity: a 32-year prospective birth cohort study. Pediatrics 2008; 122:955.
  132. Touchette E, Petit D, Tremblay RE, et al. Associations between sleep duration patterns and overweight/obesity at age 6. Sleep 2008; 31:1507.
  133. Carter PJ, Taylor BJ, Williams SM, Taylor RW. Longitudinal analysis of sleep in relation to BMI and body fat in children: the FLAME study. BMJ 2011; 342:d2712.
  134. Taveras EM, Gillman MW, Peña MM, et al. Chronic sleep curtailment and adiposity. Pediatrics 2014; 133:1013.
  135. Bonuck K, Chervin RD, Howe LD. Sleep-disordered breathing, sleep duration, and childhood overweight: a longitudinal cohort study. J Pediatr 2015; 166:632.
  136. Magee L, Hale L. Longitudinal associations between sleep duration and subsequent weight gain: a systematic review. Sleep Med Rev 2012; 16:231.
  137. Anderson SE, Andridge R, Whitaker RC. Bedtime in Preschool-Aged Children and Risk for Adolescent Obesity. J Pediatr 2016; 176:17.
  138. Wang F, Liu H, Wan Y, et al. Sleep Duration and Overweight/Obesity in Preschool-Aged Children: A Prospective Study of up to 48,922 Children of the Jiaxing Birth Cohort. Sleep 2016; 39:2013.
  139. Miller MA, Kruisbrink M, Wallace J, et al. Sleep duration and incidence of obesity in infants, children, and adolescents: a systematic review and meta-analysis of prospective studies. Sleep 2018; 41.
  140. Xiu L, Ekstedt M, Hagströmer M, et al. Sleep and Adiposity in Children From 2 to 6 Years of Age. Pediatrics 2020; 145.
  141. Hart CN, Carskadon MA, Considine RV, et al. Changes in children's sleep duration on food intake, weight, and leptin. Pediatrics 2013; 132:e1473.
  142. Lesser DJ, Bhatia R, Tran WH, et al. Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males. Pediatr Res 2012; 72:293.
  143. Koren D, Levitt Katz LE, Brar PC, et al. Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care 2011; 34:2442.
  144. Simon SL, Behn CD, Cree-Green M, et al. Too Late and Not Enough: School Year Sleep Duration, Timing, and Circadian Misalignment Are Associated with Reduced Insulin Sensitivity in Adolescents with Overweight/Obesity. J Pediatr 2019; 205:257.
  145. Klingenberg L, Chaput JP, Holmbäck U, et al. Acute Sleep Restriction Reduces Insulin Sensitivity in Adolescent Boys. Sleep 2013; 36:1085.
  146. Cespedes Feliciano EM, Quante M, Rifas-Shiman SL, et al. Objective Sleep Characteristics and Cardiometabolic Health in Young Adolescents. Pediatrics 2018; 142.
  147. Jensen CD, Duraccio KM, Barnett KA, et al. Sleep duration differentially affects brain activation in response to food images in adolescents with overweight/obesity compared to adolescents with normal weight. Sleep 2019; 42.
  148. Food and Drug Administration, changes to prescribing information for Zyprexa, released 1/4/2010 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm198402.htm (Accessed on February 01, 2010).
  149. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012; 7:91.
  150. Jess T. Microbiota, antibiotics, and obesity. N Engl J Med 2014; 371:2526.
  151. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214.
  152. Chelimo C, Camargo CA Jr, Morton SMB, Grant CC. Association of Repeated Antibiotic Exposure Up to Age 4 Years With Body Mass at Age 4.5 Years. JAMA Netw Open 2020; 3:e1917577.
  153. Wang B, Liu J, Zhang Y, et al. Prenatal Exposure to Antibiotics and Risk of Childhood Obesity in a Multicenter Cohort Study. Am J Epidemiol 2018; 187:2159.
  154. Mueller NT, Whyatt R, Hoepner L, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 2015; 39:665.
  155. Li DK, Chen H, Ferber J, Odouli R. Maternal infection and antibiotic use in pregnancy and the risk of childhood obesity in offspring: a birth cohort study. Int J Obes (Lond) 2020; 44:771.
  156. Saari A, Virta LJ, Sankilampi U, et al. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 2015; 135:617.
  157. Dogra S, Sakwinska O, Soh SE, et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 2015; 6.
  158. Schwartz BS, Pollak J, Bailey-Davis L, et al. Antibiotic use and childhood body mass index trajectory. Int J Obes (Lond) 2016; 40:615.
  159. Rasmussen SH, Shrestha S, Bjerregaard LG, et al. Antibiotic exposure in early life and childhood overweight and obesity: A systematic review and meta-analysis. Diabetes Obes Metab 2018; 20:1508.
  160. Miller SA, Wu RKS, Oremus M. The association between antibiotic use in infancy and childhood overweight or obesity: a systematic review and meta-analysis. Obes Rev 2018; 19:1463.
  161. Block JP, Bailey LC, Gillman MW, et al. Early Antibiotic Exposure and Weight Outcomes in Young Children. Pediatrics 2018; 142.
  162. Gerber JS, Bryan M, Ross RK, et al. Antibiotic Exposure During the First 6 Months of Life and Weight Gain During Childhood. JAMA 2016; 315:1258.
  163. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621.
  164. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014; 158:705.
  165. Liou AP, Paziuk M, Luevano JM Jr, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013; 5:178ra41.
  166. Cho YM. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J 2014; 38:406.
  167. Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab 2015; 22:228.
  168. Warner M, Wesselink A, Harley KG, et al. Prenatal exposure to dichlorodiphenyltrichloroethane and obesity at 9 years of age in the CHAMACOS study cohort. Am J Epidemiol 2014; 179:1312.
  169. Schecter A, Malik N, Haffner D, et al. Bisphenol A (BPA) in U.S. food. Environ Sci Technol 2010; 44:9425.
  170. Calafat AM, Ye X, Wong LY, et al. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116:39.
  171. Takai Y, Tsutsumi O, Ikezuki Y, et al. Preimplantation exposure to bisphenol A advances postnatal development. Reprod Toxicol 2001; 15:71.
  172. Somm E, Schwitzgebel VM, Toulotte A, et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 2009; 117:1549.
  173. Vom Saal FS, Nagel SC, Coe BL, et al. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 2012; 354:74.
  174. Carwile JL, Michels KB. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011; 111:825.
  175. Lang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300:1303.
  176. Melzer D, Osborne NJ, Henley WE, et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012; 125:1482.
  177. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012; 308:1113.
  178. Silventoinen K, Jelenkovic A, Sund R, et al. Genetic and environmental effects on body mass index from infancy to the onset of adulthood: an individual-based pooled analysis of 45 twin cohorts participating in the COllaborative project of Development of Anthropometrical measures in Twins (CODATwins) study. Am J Clin Nutr 2016; 104:371.
  179. Schrempft S, van Jaarsveld CHM, Fisher A, et al. Variation in the Heritability of Child Body Mass Index by Obesogenic Home Environment. JAMA Pediatr 2018; 172:1153.
  180. Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005; 90:1871.
  181. Reinehr T, Hinney A, de Sousa G, et al. Definable somatic disorders in overweight children and adolescents. J Pediatr 2007; 150:618.
  182. Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106:253.
  183. Dubern B, Bisbis S, Talbaoui H, et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr 2007; 150:613.
  184. Vollbach H, Brandt S, Lahr G, et al. Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort. Int J Obes (Lond) 2017; 41:13.
  185. Trier C, Hollensted M, Schnurr TM, et al. Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations. Int J Obes (Lond) 2021; 45:66.
  186. Farooqi IS, O'Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol 2014; 223:T63.
  187. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007; 356:237.
  188. Ozsu E, Ceylaner S, Onay H. Early-onset severe obesity due to complete deletion of the leptin gene in a boy. J Pediatr Endocrinol Metab 2017; 30:1227.
  189. Mason K, Page L, Balikcioglu PG. Screening for hormonal, monogenic, and syndromic disorders in obese infants and children. Pediatr Ann 2014; 43:e218.
  190. Bougnères P, Pantalone L, Linglart A, et al. Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J Clin Endocrinol Metab 2008; 93:3971.
  191. Ize-Ludlow D, Gray JA, Sperling MA, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics 2007; 120:e179.
  192. Mantzoros CS, Rifas-Shiman SL, Williams CJ, et al. Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study. Pediatrics 2009; 123:682.
  193. Gillman MW, Ludwig DS. How early should obesity prevention start? N Engl J Med 2013; 369:2173.
  194. van Abeelen AF, Veenendaal MV, Painter RC, et al. Survival effects of prenatal famine exposure. Am J Clin Nutr 2012; 95:179.
  195. Ravelli AC, van Der Meulen JH, Osmond C, et al. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999; 70:811.
  196. Roseboom TJ, van der Meulen JH, Osmond C, et al. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr 2000; 72:1101.
  197. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006; 82:485.
  198. Lumey LH, Ekamper P, Bijwaard G, et al. Overweight and obesity at age 19 after pre-natal famine exposure. Int J Obes (Lond) 2021; 45:1668.
  199. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351:173.
  200. de Rooij SR, Painter RC, Roseboom TJ, et al. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 2006; 49:637.
  201. Voerman E, Santos S, Patro Golab B, et al. Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant data meta-analysis. PLoS Med 2019; 16:e1002744.
  202. Efstathiou SP, Skeva II, Zorbala E, et al. Metabolic syndrome in adolescence: can it be predicted from natal and parental profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) study. Circulation 2012; 125:902.
  203. Ludwig DS, Currie J. The association between pregnancy weight gain and birthweight: a within-family comparison. Lancet 2010; 376:984.
  204. Deierlein AL, Siega-Riz AM, Adair LS, Herring AH. Effects of pre-pregnancy body mass index and gestational weight gain on infant anthropometric outcomes. J Pediatr 2011; 158:221.
  205. Castillo H, Santos IS, Matijasevich A. Relationship between maternal pre-pregnancy body mass index, gestational weight gain and childhood fatness at 6-7 years by air displacement plethysmography. Matern Child Nutr 2015; 11:606.
  206. Lau EY, Liu J, Archer E, et al. Maternal weight gain in pregnancy and risk of obesity among offspring: a systematic review. J Obes 2014; 2014:524939.
  207. Sridhar SB, Darbinian J, Ehrlich SF, et al. Maternal gestational weight gain and offspring risk for childhood overweight or obesity. Am J Obstet Gynecol 2014; 211:259.e1.
  208. Richmond RC, Timpson NJ, Felix JF, et al. Using Genetic Variation to Explore the Causal Effect of Maternal Pregnancy Adiposity on Future Offspring Adiposity: A Mendelian Randomisation Study. PLoS Med 2017; 14:e1002221.
  209. Kral JG, Biron S, Simard S, et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics 2006; 118:e1644.
  210. Davey Smith G, Steer C, Leary S, Ness A. Is there an intrauterine influence on obesity? Evidence from parent child associations in the Avon Longitudinal Study of Parents and Children (ALSPAC). Arch Dis Child 2007; 92:876.
  211. Chiavaroli V, Giannini C, D'Adamo E, et al. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics 2009; 124:695.
  212. Renom Espineira A, Fernandes-Rosa FL, Bueno AC, et al. Postnatal growth and cardiometabolic profile in young adults born large for gestational age. Clin Endocrinol (Oxf) 2011; 75:335.
  213. Wang G, Divall S, Radovick S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA 2014; 311:587.
  214. Huxley R, Owen CG, Whincup PH, et al. Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 2007; 85:1244.
  215. Barker DJ, Winter PD, Osmond C, et al. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2:577.
  216. Li Y, Ley SH, Tobias DK, et al. Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study. BMJ 2015; 351:h3672.
  217. Wang N, Wang X, Han B, et al. Is Exposure to Famine in Childhood and Economic Development in Adulthood Associated With Diabetes? J Clin Endocrinol Metab 2015; 100:4514.
  218. Moore BF, Harrall KK, Sauder KA, et al. Neonatal Adiposity and Childhood Obesity. Pediatrics 2020; 146.
  219. Lawlor DA, Lichtenstein P, Långström N. Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood: sibling study in a prospective cohort of 280,866 men from 248,293 families. Circulation 2011; 123:258.
  220. Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129:e1552.
  221. Washburn L, Nixon P, Russell G, et al. Adiposity in adolescent offspring born prematurely to mothers with preeclampsia. J Pediatr 2013; 162:912.
  222. Seidman DS, Laor A, Gale R, et al. Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-age. Br J Obstet Gynaecol 1991; 98:1009.
  223. Ogland B, Vatten LJ, Romundstad PR, et al. Pubertal anthropometry in sons and daughters of women with preeclamptic or normotensive pregnancies. Arch Dis Child 2009; 94:855.
  224. Fraser A, Tilling K, Macdonald-Wallis C, et al. Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation 2010; 121:2557.
  225. Taveras EM, Rifas-Shiman SL, Sherry B, et al. Crossing growth percentiles in infancy and risk of obesity in childhood. Arch Pediatr Adolesc Med 2011; 165:993.
  226. Smego A, Woo JG, Klein J, et al. High Body Mass Index in Infancy May Predict Severe Obesity in Early Childhood. J Pediatr 2017; 183:87.
  227. Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 2009; 301:2234.
  228. Monteiro PO, Victora CG. Rapid growth in infancy and childhood and obesity in later life--a systematic review. Obes Rev 2005; 6:143.
  229. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr 2006; 95:904.
  230. Owen CG, Martin RM, Whincup PH, et al. Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics 2005; 115:1367.
  231. Baird J, Fisher D, Lucas P, et al. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ 2005; 331:929.
  232. Belfort MB, Rifas-Shiman SL, Rich-Edwards J, et al. Size at birth, infant growth, and blood pressure at three years of age. J Pediatr 2007; 151:670.
  233. Shehadeh N, Weitzer-Kish H, Shamir R, et al. Impact of early postnatal weight gain and feeding patterns on body mass index in adolescence. J Pediatr Endocrinol Metab 2008; 21:9.
  234. Gardner DS, Hosking J, Metcalf BS, et al. Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36). Pediatrics 2009; 123:e67.
  235. Skilton MR, Marks GB, Ayer JG, et al. Weight gain in infancy and vascular risk factors in later childhood. Pediatrics 2013; 131:e1821.
  236. Koletzko B, von Kries R, Closa R, et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr 2009; 89:1836.
  237. Weber M, Grote V, Closa-Monasterolo R, et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr 2014; 99:1041.
  238. Pimpin L, Jebb S, Johnson L, et al. Dietary protein intake is associated with body mass index and weight up to 5 y of age in a prospective cohort of twins. Am J Clin Nutr 2016; 103:389.
  239. Yeung MY. Postnatal growth, neurodevelopment and altered adiposity after preterm birth--from a clinical nutrition perspective. Acta Paediatr 2006; 95:909.
  240. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998; 317:1481.
  241. Thureen PJ. The neonatologist's dilemma: catch-up growth or beneficial undernutrition in very low birth weight infants-what are optimal growth rates? J Pediatr Gastroenterol Nutr 2007; 45 Suppl 3:S152.
  242. Kerkhof GF, Willemsen RH, Leunissen RW, et al. Health profile of young adults born preterm: negative effects of rapid weight gain in early life. J Clin Endocrinol Metab 2012; 97:4498.
Topic 5874 Version 159.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟